Anugerah 88

46.97

+0.76|(+1.64%)

52W H: 62.3252W L: 14.785Beta: 0.56

About Enliven Therapeutics Inc

Industry: Pharmaceuticals
Exchange: NASDAQ NMS - GLOBAL MARKET
Country: US
Website: https://www.enliventherapeutics.com/

Frequently Asked Questions

What is the 52-week range for ELVN?

The 52-week high is $62.32 and the 52-week low is $14.785.

What is the P/E ratio for ELVN?

The P/E ratio data is currently unavailable.

What is the dividend yield for ELVN?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -18.55%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.99.

Analyst Recommendation Trends

Wall Street analyst consensus for ELVN over the last few months:

2026-09-01

Buy: 11

S.Buy: 8

Hold: 1

Sell: 0

2026-08-01

Buy: 10

S.Buy: 7

Hold: 1

Sell: 0

2026-07-01

Buy: 10

S.Buy: 7

Hold: 1

Sell: 0

2026-06-01

Buy: 10

S.Buy: 6

Hold: 1

Sell: 0

Latest ELVN News

This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated coverage: VYLR Outperform/$85, LBRX Buy/$68, ELVN Overweight/$70, SAIL Sector Weight, and AVLN Outperform/$60.

Benzinga10/2/2026

Morgan Stanley Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $70

Morgan Stanley analyst Sean Laaman initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Overweight rating and announces Price Target of $70.

Benzinga10/2/2026

JP Morgan Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $75

JP Morgan analyst Priyanka Grover initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Overweight rating and announces Price Target of $75.

Benzinga10/1/2026

Enliven Therapeutics, Inc. (ELVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Enliven Therapeutics, Inc. (ELVN) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDTCompany ParticipantsRichard Fair -...

SeekingAlpha9/16/2026

Enliven Therapeutics to Present at Upcoming Investor Conferences

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in the following investor conferences:

Yahoo9/3/2026

Enliven Therapeutics: A Clean Active-Site TKI Could Redefine CML Sequencing

Enliven Therapeutics is positioned as a late-stage, well-capitalized biotech with $895M cash, funding operations into 2030. Read more on ELVN stock here.

SeekingAlpha9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to ELVN:

EWTX INDV CURA.TO OGN AMLX ELVN TARS MBX LQDA SUPN AMRX LLY

Recent Insider Transactions

Date	Name	Shares Changed	Price	Value
2026-09-17	Hohl Benjamin	-3,982	-	-
2026-09-17	Hohl Benjamin	-289	$51.4929	$14,881
2026-09-17	Hohl Benjamin	-2,194	$50.7158	$111,270
2026-09-17	Hohl Benjamin	-3,535	$50.0286	$176,851
2026-09-17	Hohl Benjamin	+3,982	$14.85	$59,133
2026-09-17	Collins Helen Louise	-5,000	-	-
2026-09-17	Collins Helen Louise	-240	$51.482	$12,356
2026-09-17	Collins Helen Louise	-1,844	$50.7089	$93,507
2026-09-17	Collins Helen Louise	-2,916	$50.0312	$145,891
2026-09-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-08-17	Hohl Benjamin	-1,388	$59.3536	$82,383
2026-08-17	Hohl Benjamin	-4,630	$58.3517	$270,168
2026-08-17	Collins Helen Louise	-5,000	-	-
2026-08-17	Collins Helen Louise	-1,100	$59.3465	$65,281
2026-08-17	Collins Helen Louise	-3,900	$58.3717	$227,650
2026-08-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-08-04	Derynck Mika K	-20,491	-	-
2026-08-04	Derynck Mika K	-23,364	-	-
2026-08-04	Derynck Mika K	-27,567	-	-
2026-08-04	Derynck Mika K	-87,373	-	-
2026-08-04	Derynck Mika K	-158,795	$60.2134	$9,561,587
2026-08-04	Derynck Mika K	+20,491	$22.47	$460,433
2026-08-04	Derynck Mika K	+23,364	$14.85	$346,955
2026-08-04	Derynck Mika K	+27,567	$25.28	$696,894
2026-08-04	Derynck Mika K	+87,373	$2.48	$216,685
2026-07-17	Hohl Benjamin	-1,072	-	-
2026-07-17	Hohl Benjamin	-123	$53.8716	$6,626
2026-07-17	Hohl Benjamin	-2,638	$53.3825	$140,823
2026-07-17	Hohl Benjamin	-2,564	$52.318	$134,143
2026-07-17	Hohl Benjamin	-369	$51.4823	$18,997
2026-07-17	Hohl Benjamin	-324	$49.9715	$16,191
2026-07-17	Hohl Benjamin	+1,072	$2.48	$2,659
2026-07-17	Collins Helen Louise	-5,000	-	-
2026-07-17	Collins Helen Louise	-63	$53.9208	$3,397
2026-07-17	Collins Helen Louise	-2,184	$53.4199	$116,669
2026-07-17	Collins Helen Louise	-2,063	$52.3921	$108,085
2026-07-17	Collins Helen Louise	-459	$51.5466	$23,660
2026-07-17	Collins Helen Louise	-231	$50.0542	$11,563
2026-07-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-07-06	Kunkel Lori Anne	-5,889	$50.8442	$299,421
2026-07-06	Kunkel Lori Anne	-4,111	$49.9834	$205,482
2026-06-22	ORBIMED ADVISORS LLC	-46,776	$45	$2,104,920
2026-06-22	ORBIMED ADVISORS LLC	-787,024	$45.38	$35,715,149
2026-06-22	ORBIMED ADVISORS LLC	-1,477	$45	$66,465
2026-06-22	ORBIMED ADVISORS LLC	-24,846	$45.38	$1,127,511
2026-06-17	Hohl Benjamin	-6,018	-	-
2026-06-17	Hohl Benjamin	-1,238	$44.7475	$55,397
2026-06-17	Hohl Benjamin	-3,401	$43.8634	$149,179
2026-06-17	Hohl Benjamin	-1,379	$42.785	$59,001
2026-06-17	Hohl Benjamin	+6,018	$2.48	$14,925
2026-06-17	Collins Helen Louise	-5,000	-	-
2026-06-17	Collins Helen Louise	-1,133	$44.743	$50,694
2026-06-17	Collins Helen Louise	-2,599	$43.8701	$114,018
2026-06-17	Collins Helen Louise	-1,268	$42.827	$54,305
2026-06-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-06-15	ORBIMED ADVISORS LLC	-272,322	$45.02	$12,259,936
2026-06-15	ORBIMED ADVISORS LLC	-9,086	$45.02	$409,052
2026-06-05	Kunkel Lori Anne	-354	$35.8187	$12,680
2026-06-05	Kunkel Lori Anne	-1,867	$35.3573	$66,012
2026-06-05	Kunkel Lori Anne	-7,779	$34.2794	$266,659
2026-05-18	Collins Helen Louise	-5,000	-	-
2026-05-18	Collins Helen Louise	-223	$41.2052	$9,189
2026-05-18	Collins Helen Louise	-1,302	$40.2473	$52,402
2026-05-18	Collins Helen Louise	-3,475	$39.534	$137,381
2026-05-18	Collins Helen Louise	+5,000	$2.48	$12,400
2026-04-17	Collins Helen Louise	-5,000	-	-
2026-04-17	Collins Helen Louise	-2,441	$48.0555	$117,303
2026-04-17	Collins Helen Louise	-2,419	$47.3896	$114,635
2026-04-17	Collins Helen Louise	-140	$45.8107	$6,413
2026-04-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-03-25	Collins Helen Louise	-40,000	-	-
2026-03-25	Collins Helen Louise	-40,000	$35.1006	$1,404,024
2026-03-25	Collins Helen Louise	+40,000	$2.48	$99,200
2026-03-17	Collins Helen Louise	-5,000	-	-
2026-03-17	Collins Helen Louise	-5,000	$27.76	$138,800
2026-03-17	Collins Helen Louise	+5,000	$2.48	$12,400
2026-03-10	Collins Helen Louise	-10,129	-	-
2026-03-10	Collins Helen Louise	-10,129	$30.1932	$305,827
2026-03-10	Collins Helen Louise	+10,129	$2.48	$25,120
2026-03-09	Collins Helen Louise	-29,871	-	-
2026-03-09	Collins Helen Louise	-29,871	$30.0228	$896,811
2026-03-09	Collins Helen Louise	+29,871	$2.48	$74,080
2026-03-06	Hohl Benjamin	-10,000	$29.5839	$295,839
2026-02-17	Collins Helen Louise	-45,000	-	-
2026-02-17	Collins Helen Louise	-45,000	$26.1747	$1,177,862
2026-02-17	Collins Helen Louise	+45,000	$2.48	$111,600
2026-02-17	Heyman Richard A.	-1,230	$26.1759	$32,196
2026-02-12	Patel Anish	+120,000	-	-
2026-02-12	Patel Anish	+20,000	-	-
2026-02-12	Lyssikatos Joseph P	+112,500	-	-
2026-02-12	Lyssikatos Joseph P	+18,750	-	-
2026-02-12	Hohl Benjamin	+150,000	-	-
2026-02-12	Hohl Benjamin	+25,000	-	-
2026-02-12	Derynck Mika K	+17,126	-	-
2026-02-12	Ballal Rahul D.	+17,126	-	-
2026-02-12	Collins Helen Louise	+150,000	-	-
2026-02-12	Collins Helen Louise	+25,000	-	-
2026-02-12	Bauer Jake	+17,126	-	-
2026-02-12	Heyman Richard A.	+19,234	-	-
2026-02-12	Gupta Rishi	+1,580	-	-
2026-02-12	Gupta Rishi	+33,989	-	-
2026-02-12	Kunkel Lori Anne	+17,126	-	-
2026-02-12	Garland J. Scott	+1,427	-	-
2026-02-06	Lyssikatos Joseph P	-5,000	$29.0438	$145,219
2026-01-20	Lyssikatos Joseph P	-14,509	$26.8995	$390,285
2026-01-20	Lyssikatos Joseph P	-5,491	$26.373	$144,814
2026-01-20	Heyman Richard A.	-718	$26.956	$19,354
2026-01-20	Heyman Richard A.	-512	$26.4592	$13,547
2026-01-09	Patel Anish	-243	$28.5	$6,926
2026-01-09	Patel Anish	-48,057	$27.9842	$1,344,837
2026-01-09	Lyssikatos Joseph P	-50,000	$29.1343	$1,456,715
2026-01-09	Lyssikatos Joseph P	-41,198	$24.9008	$1,025,863
2026-01-09	Heyman Richard A.	-4,285	$25.0001	$107,125
2026-01-08	Lyssikatos Joseph P	-33,802	$24.9238	$842,474
2026-01-08	Lyssikatos Joseph P	-7,500	$20.1282	$150,962
2026-01-08	Heyman Richard A.	-8,015	$25.035	$200,656
2026-01-08	Heyman Richard A.	-1,620	$25	$40,500
2026-01-07	Garland J. Scott	+59,372	-	-
2025-12-22	Hohl Benjamin	-13,000	-	-
2025-12-22	Hohl Benjamin	+13,000	$2.48	$32,240
2025-12-19	Lyssikatos Joseph P	-5,000	$16.8412	$84,206
2025-12-17	Kunkel Lori Anne	-15,958	-	-
2025-12-17	Kunkel Lori Anne	+15,958	$1.12	$17,873
2025-12-11	Fair Richard A.	+875,000	-	-
2025-12-08	Patel Anish	-1,705	$21.7794	$37,134
2025-12-08	Patel Anish	-4,958	$20.7622	$102,939
2025-11-19	Lyssikatos Joseph P	-492	$23.091	$11,361
2025-11-19	Lyssikatos Joseph P	-12,008	$22.3013	$267,794
2025-11-17	Kintz Samuel	-12,500	$21.8191	$272,739
2025-11-07	Patel Anish	-613	$17.9371	$10,995
2025-11-07	Patel Anish	-6,054	$17.3503	$105,039
2025-10-20	Lyssikatos Joseph P	-12,500	$22.082	$276,025
2025-10-17	Kintz Samuel	-12,500	$21.3323	$266,654
2025-10-07	Patel Anish	-6,667	$20.0979	$133,993